A detailed history of Keeley Teton Advisors, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Keeley Teton Advisors, LLC holds 6,360 shares of HAE stock, worth $492,327. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,360
Previous 6,360 -0.0%
Holding current value
$492,327
Previous $526,000 2.85%
% of portfolio
0.06%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$72.75 - $90.6 $36,375 - $45,300
500 Added 8.53%
6,360 $526,000
Q4 2022

Feb 10, 2023

BUY
$73.85 - $86.14 $107,820 - $125,764
1,460 Added 33.18%
5,860 $460,000
Q1 2022

May 18, 2022

BUY
$43.77 - $63.22 $192,588 - $278,168
4,400 New
4,400 $278,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.97B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Keeley Teton Advisors, LLC Portfolio

Follow Keeley Teton Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keeley Teton Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keeley Teton Advisors, LLC with notifications on news.